Online Only Articles

Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure

Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory, PA, USA
Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA
St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA
University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA;University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
Vol. 103 No. 9 (2018): September, 2018 https://doi.org/10.3324/haematol.2018.192088